TeraPore Technologies
Pre-clinicalNovel biologics require novel virus filtration solutions. At TeraPore, we use tunable self-assembled block copolymer technology to bring to market novel nanofiltration products that address the most complex separation challenges in biopharmaceutical production and semiconductor manufacturing.
Founded
2015
Focus
Drug DeliveryBiologics
About
Novel biologics require novel virus filtration solutions. At TeraPore, we use tunable self-assembled block copolymer technology to bring to market novel nanofiltration products that address the most complex separation challenges in biopharmaceutical production and semiconductor manufacturing.
Funding History
2Total raised: $14.5M
Series A$12MUndisclosedNov 15, 2020
Seed$2.5MUndisclosedMay 15, 2018
Company Info
TypePrivate
Founded2015
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile